Condition: Pulmonary Hypertension Associated With HFpEF · Sponsor: Tenax Therapeutics, Inc.
The purpose of this study is to assess the efficacy and safety of the study drug, levosimendan (given orally), compared to placebo in participants with pulmonary hypertension with heart failure with preserved left ventricular ejection fraction (PH-HFpEF) as measured by the change in 6-Minute Walk Distance.
This description comes directly from the study's public registry record.
Akshata Ashokkumar · (919) 855-2118 · a.ashokkumar@tenaxthera.com
Katelyn Jansson · (919) 855-2119 · k.jansson@tenaxthera.com
Always discuss trial participation with your own doctor first.
| Tenax Investigational Site | Alexander City, Alabama, United States | Recruiting |
| Tenax Investigational Site | Tamarac, Florida, United States | Not Yet Recruiting |
| Tenax Investigational Site | Mount Prospect, Illinois, United States | Not Yet Recruiting |
| Tenax Investigational Site | Peoria, Illinois, United States | Recruiting |
| Tenax Investigational Site | New Orleans, Louisiana, United States | Recruiting |
| Tenax Investigational Site | West Monroe, Louisiana, United States | Recruiting |
| Tenax Investigational Site | Ypsilanti, Michigan, United States | Not Yet Recruiting |
| Tenax Investigational Site | Reno, Nevada, United States | Recruiting |
| Tenax Investigational Site | New York, New York, United States | Not Yet Recruiting |
| Tenax Investigational Site | Winston-Salem, North Carolina, United States | Recruiting |
| Tenax Investigational Site | Allentown, Pennsylvania, United States | Not Yet Recruiting |
| Tenax Investigational Site | Wynnewood, Pennsylvania, United States | Not Yet Recruiting |
+ 80 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07288398